IP Library Granted Patent US 12,333,413
Granted Patent B1
US 12,333,413 · App. 18/592,680 · Granted Jun 17, 2025

Apparatus and method for training an artificial intelligence-supported diagnostic assessment tool

Inventors: Eunjung Lee (Rochester, MN); Francisco Lopez-Jimenez (Rochester, MN); Paul A. Friedman (Rochester, MN); Itzhak Zachi Attia (Rochester, MN); Jae K. Oh (Rochester, MN)
Assignee: Mayo Foundation for Medical Education and Research
G06N3/0464A61B5/349A61B8/0883G16H50/20G16H30/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,333,413
App. No.
18/592,680
Granted
Jun 17, 2025
Kind
B1
Abstract

An apparatus and method for training an artificial intelligence-supported diagnostic assessment tool may provide rapid and accurate prognosis determinations. Apparatus may include at least a processor configured to receive a plurality of multi-channel sensor readings of physiological data, generate training data correlating each of the plurality of multi-channel sensor readings with a plurality of diagnostic labels, train a neural network using the plurality of diagnostic labels, receive a time series input describing user physiological data from at least a sensor, input the time series input into the trained neural network, generate diagnostic data as a function of the time series input and the trained neural network, determine prognostic data as a function of the diagnostic data, and output the prognostic data.

Claims (49)

1. An apparatus for artificial intelligence-supported diagnostic assessment, wherein the apparatus comprises: a sensor for sensing a time series input;

at least a processor, wherein the processor is configured to:

receive a plurality of multi-channel sensor readings of physiological data;

generate training data correlating each of the plurality of multi-channel sensor readings with a plurality of diagnostic labels;

train a neural network using the plurality of diagnostic labels;

update the training data as a function of new training examples;

retrain the neural network as a function of the updated training data, wherein the retraining occurs when a preconfigured threshold of new training examples is exceeded;

receive the time series input describing user physiological data from at least the sensor;

input the time series input into the trained neural network;

generate diagnostic data as a function of the time series input and the trained neural network, wherein the diagnostic data includes a classification under a plurality of groups, wherein the groups are comprised of:

normal LV function;

LVSD only;

LVDD only; and

both LVSD and LVDD;

determine prognostic data as a function of the diagnostic data; and

output the prognostic data; and a display device, wherein the output of the prognostic data is displayed on the display device.

2. The apparatus of claim 1 , wherein the time series input is comprised of electrocardiogram (ECG) data.

3. The apparatus of claim 2 , wherein the plurality of multi-channel sensor readings further comprises a plurality of ECG readings, and the plurality of training data further comprises the plurality of ECG readings, and generating the plurality of training data further comprises:

receiving echocardiogram data correlated to each ECG reading of the plurality of ECG readings; and

generating the plurality of diagnostic labels using the echocardiogram data.

4. The apparatus of claim 1 , wherein the neural network is a multi-output convolutional neural network.

5. The apparatus of claim 1 , wherein the neural network is trained using general-use lead data, wherein the general-use lead data refers to the lead data used for a diagnostic tool.

6. The apparatus of claim 1 , wherein the neural network is trained using reduced general-use lead data, wherein the reduced general-use lead data refers to a reduction in the leads used in acquiring the lead data.

7. The apparatus of claim 1 , wherein the neural network is trained as a function of lead data gathered from 12-lead ECGs performed within 14 days of transthoracic echocardiography, wherein the plurality of multi-channel sensor readings of physiological data are comprised of the 12-lead ECG data and the lead data correlated to each 12-lead ECG datum.

8. The apparatus of claim 1 , wherein the diagnostic data includes an assessment of the LVDD.

9. A method for training an artificial intelligence-supported diagnostic assessment tool, wherein the method comprises: sensing a time series input via a sensor;

receiving a plurality of multi-channel sensor readings of physiological data;

generating training data correlating each of the plurality of multi-channel sensor readings with a plurality of diagnostic labels;

training a neural network using the plurality of diagnostic labels;

updating the training data as a function of new training examples;

retraining the neural network as a function of the updated training data, wherein the retraining occurs when a preconfigured threshold of new training examples is exceeded;

receiving the time series input describing user physiological data from at least the sensor;

inputting the time series input into the trained neural network;

generating diagnostic data as a function of the time series input and the trained neural network, wherein the diagnostic data includes a classification under a plurality of groups, wherein the groups are comprised of:

normal LV function;

LVSD only;

LVDD only; and

both LVSD and LVDD;

determining prognostic data as a function of the diagnostic data; and

outputting the prognostic data; and displaying the output of the prognostic data on a display device.

10. The method of claim 9 , wherein the time series input is comprised of electrocardiogram (ECG) data.

11. The method of claim 10 , wherein the plurality of multi-channel sensor readings further comprises a plurality of ECG readings, and the plurality of training data further comprises the plurality of ECG readings, and generating the plurality of training data further comprises:

receiving echocardiogram data correlated to each ECG reading of the plurality of ECG readings; and

generating the plurality of diagnostic labels using the echocardiogram data.

12. The method of claim 9 , wherein the neural network is a multi-output convolutional neural network.

13. The method of claim 9 , wherein the neural network is trained using general-use lead data, wherein the general-use lead data refers to the lead data used for a diagnostic tool.

14. The method of claim 9 , wherein the neural network is trained using reduced general-use lead data, wherein the reduced general-use lead data refers to a reduction in the leads used in acquiring the lead data.

15. The method of claim 9 , wherein the neural network is trained using lead data gathered from 12-lead ECGs performed within 14 days of transthoracic echocardiography, wherein the plurality of multi-channel sensor readings of physiological data are comprised of the 12-lead ECG data and the lead data correlated to each 12-lead ECG datum.

16. The method of claim 9 , wherein the diagnostic data includes an assessment of both the LVSD and the LVDD.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2024
From: LEE, EUNJUNG; LOPEZ-JIMENEZ, FRANCISCO; FRIEDMAN, PAUL A.; ATTIA, ITZHAK ZACHI; OH, JAE K.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 069339/0971 →
References Cited (17)
US 11445918B2 · Peterson · 2022 [cited by applicant]
US 11589829B2 · Khosousi et al. · 2023 [cited by applicant]
US 11657921B2 · Zimmerman et al. · 2023 [cited by applicant]
US 20200397313A1 · Attia et al. · 2020 [cited by applicant]
US 20220000041A1 · Baram · 2022 [cited by applicant]
US 20220189634A1 · Wagner et al. · 2022 [cited by applicant]
US 20220189636A1 · Wagner et al. · 2022 [cited by applicant]
US 20230309967A1 · Vaid et al. · 2023 [cited by applicant]
US 20230395248A1 · Sipe et al. · 2023 [cited by applicant]
WO 2023230345A1 · 2023 [cited by applicant]
WO WO2023230345 · 2023 [cited by examiner]
Chen et al., “Artificial Intelligence-Enable Electrocardiogramtricular Dysfunction and Future Cardiovascular Outcomes: A Retrospective Analysis”, Mar. 2022, Journal of Personalized Medicine (Year: 2022). [cited by examiner]
Kashou et al.; Artificial intelligence—augmented electrocardiogram detection of left ventricular systolic dysfunction in the general population; Mayo Clinic proceedings, vol. 96, No. 10, pp. 2576-2586; Oct. 1, 2021; Ret… [cited by applicant]
Chen et al.; Artificial intelligence-enabled electrocardiogramtricular dysfunction and future cardiovascular outcomes: a retrospective analysis; Journal of Personalized Medicine 12, No. 3: 455; Mar. 13, 2022; Retrieved … [cited by applicant]
Huang et al.; Artificial intelligence-enabled electrocardiogrameening for left ventricular systolic dysfunction and mortality risk prediction; Frontiers in Cardiovascular Medicine 10: 1070641; Mar. 3, 2023; Retrieved at… [cited by applicant]
Bjerken et al.; Artificial intelligence enabled ECG screening for left ventricular systolic dysfunction: a systematic review; Heart Failure Reviews 28, No. 2: 419-430; Nov. 8, 2022; Retrieved at https://link.springer.co… [cited by applicant]
Naz et al., From ECG signals to images: a transformation based approach for deep learning, (journal), Feb. 10, 2021, PeerJ Computer Science, 7: e386, National Library of Medicine. [cited by applicant]